Yadav S, Kanwar Aj, Parsad D, Minz Rw
Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Dermatol. 2013 Jul;58(4):325. doi: 10.4103/0019-5154.113932.
Autologous serum skin test (ASST) is the most commonly used laboratory test to differentiate chronic autoimmune urticaria patients from chronic idiopathic urticaria patients without autoantibodies. Thyroid autoimmunity is the original paradigm for autoimmune disease in general and many previous studies show increased prevalence of thyroid autoantibodies and deranged thyroid hormone profile in chronic idiopathic urticaria patients.
To find the association between thyroid autoimmunity and chronic autoimmune urticaria, if any.
The chronic idiopathic urticaria patients were divided into two subgroups based on autologous serum skin test. Thyroid autoantibodies were estimated in 40 patients each of ASST positive and ASST negative groups. Further, thyroid hormone profile was done in cases with significant titers of thyroid autoantibodies. Forty patients, who had never suffered from urticaria, represented the control group.
The prevalence of thyroid autoantibodies did not differ significantly among the ASST positive (20%) and ASST negative patients (15%). The control group had low prevalence of these autoantibodies (5%).
The almost equal prevalence of thyroid autoantibodies in two subgroups of chronic idiopathic urticaria patients suggests possibly the same etiopathogenesis of the two subgroups. The two subgroups probably form a continuum, or even may be the same entity.
自体血清皮肤试验(ASST)是用于区分慢性自身免疫性荨麻疹患者与无自身抗体的慢性特发性荨麻疹患者的最常用实验室检查。甲状腺自身免疫是一般自身免疫性疾病的原始范例,许多先前的研究表明慢性特发性荨麻疹患者中甲状腺自身抗体的患病率增加以及甲状腺激素水平紊乱。
探究甲状腺自身免疫与慢性自身免疫性荨麻疹之间是否存在关联。
根据自体血清皮肤试验将慢性特发性荨麻疹患者分为两个亚组。分别对40例ASST阳性和40例ASST阴性组的患者进行甲状腺自身抗体检测。此外,对甲状腺自身抗体滴度显著的患者进行甲状腺激素水平检测。40例从未患过荨麻疹的患者作为对照组。
ASST阳性患者(20%)和ASST阴性患者(15%)的甲状腺自身抗体患病率无显著差异。对照组这些自身抗体的患病率较低(5%)。
慢性特发性荨麻疹患者两个亚组中甲状腺自身抗体患病率几乎相等,提示这两个亚组可能具有相同的发病机制。这两个亚组可能形成一个连续体,甚至可能是同一实体。